Seymour June Ann has filed 3 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 6500 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Seymour June Ann | Chief Accounting Officer | A | Common Stock | 6500 | $0.00 | 6,500.0000 | 26,003,606 | 9999.99% | 0.02% |
| Jan. 2, 2026 | Cartesian Therapeutics, Inc. | $RNAC | Seymour June Ann | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 19000 | $0.00 | 19,000.0000 | 26,003,606 | 9999.99% | 0.07% |
| Oct. 27, 2025 | Cartesian Therapeutics, Inc. | $RNAC | Seymour June Ann | Chief Accounting Officer | A | Employee Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 26,003,606 | 9999.99% | 0.19% |